Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease
This study has been withdrawn prior to recruitment.
( Study withdrawn with intent of persuing larger, multi-site study. )
Study NCT00584090 Information provided by University of South Florida
First Received: December 21, 2007 Last Updated: June 2, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Urinary Incontinence
Parkinson's Disease
Additional conditions recognized in this trial
Parkinson Disease
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Solifenacin Succinate (VESIcare)
Placebo
Additional drug interventions recognized in this trial
Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate
More general drug interventions related to this trial
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of South Florida
Back to top of Main Content
